This Biotech with Breakout MS Drug Draws Big Investment
A breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Success in Zero Based Budgeting comes from clear priorities and routine monitoring. Build consistency with simple benchmarks and alerts.
20,252 articlesA breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
ASML delivered a powerhouse quarter that suggests AI infrastructure spending remains resilient. With Intel set to rep...
Space-based power could unlock sustainable habitats beyond Earth. This guide explains what space nuclear power invest...
Unity Software’s latest guidance sparked a sharp rally, underscoring how Vector AI could redefine monetization in int...
A Brazilian fund made a sizable bet on MercadoLibre even as the stock slid over the past year. This article unpacks t...
The phrase oklo stock sinking today captures the mood around Oklo’s latest earnings and market reaction. This guide b...
A bold alliance between Allseas and a mining innovator aims to commercialize deep-sea nodule recovery. This strategic...
Two popular ETFs populate the healthcare investing scene: PPH focuses narrowly on drugmakers, while IXJ spans the bro...
Gossamer Bio's 2026 earnings outlook centers on cash runway, pipeline progress, and strategic partnerships. This arti...
Nu Holdings already has more customers than many U.S. banks. The bigger question for investors is: how much revenue c...
A historic moment lights up global headlines as Melania Trump takes the gavel to chair a UN Security Council meeting....
California luxury builder Thomas James Homes announces a new growth plan under CEO Steve Schlageter, centering on pre...